# GRTXD (Galera Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Galera Therapeutics, Inc. reported $6.16M in total assets and net income of $149.0M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/GRTXD
- Markdown: https://convexityos.com/fundamentals/GRTXD.md
- SEC CIK: 0001563577
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:26 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001563577&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$2.23M | Operating profit |
| Net Income | FY 2025 | $149.0M | GAAP bottom line |
| Diluted EPS | FY 2025 | $1.51 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $5.50M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $349K | $3.15M | $24.11M | $31.01M | $52.42M | $54.84M | $42.33M | $18.66M |
| **Operating Income** | -$2.54M | -$20.16M | -$49.26M | -$51.23M | -$73.37M | -$70.55M | -$50.69M | -$24.25M |
| **EBITDA** | -$2.54M | -$20.14M | -$49.00M | -$51.11M | -$72.59M | -$70.19M | -$50.42M | -$24.13M |
| Interest Income | $248K | $554K | $1.59M | $506K | $32K | $1.17M | $1.82M | $606K |
| Interest Expense | $0 | $0 | $11.41M | $11.57M | $7.19M | $4.88M | $3.03M | $220K |
| Income Before Tax | $149.0M | -$19.16M | -$59.08M | -$62.29M | -$80.53M | -$74.23M | -$51.94M | -$23.90M |
| Income Tax Expense | $0 | -$203K | $0 | $70K | $0 | -$16K | -$9.0K | -$223K |
| **Net Income** | $149.0M | -$18.96M | -$59.08M | -$62.22M | -$80.53M | -$74.22M | -$51.93M | -$23.68M |
| Basic EPS | $0.64 | -$0.34 | -$1.33 | -- | -$3.12 | -$2.98 | -$16.31 | -$98.42 |
| **Diluted EPS** | $0.64 | -$0.34 | -$1.33 | -- | -$3.12 | -$2.98 | -$16.31 | -$98.42 |
| Basic Shares Outstanding | 98.5M | 54.6M | 44.5M | -- | 25.8M | 24.9M | 3.6M | 300.6K |
| Diluted Shares Outstanding | 98.5M | 54.6M | 44.5M | -- | 25.8M | 24.9M | 3.6M | 300.6K |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $15K | $42K | $130K | $84K | $93K | -$72K | $305K | $1.43M |
| **Operating Income** | -$1.66M | $1.99M | -$1.44M | -$1.14M | -$1.96M | -$5.47M | -$5.91M | -$4.21M |
| **EBITDA** | -- | $1.99M | -$1.44M | -$1.14M | -$1.96M | -$5.47M | -$5.90M | -$4.20M |
| Interest Income | $49K | $63K | $48K | $60K | $77K | $83K | $126K | $149K |
| Interest Expense | $0 | $0 | $0 | -- | $0 | $0 | $0 | $0 |
| Income Before Tax | -- | -- | -$1.39M | -- | -- | -- | -$5.78M | -- |
| Income Tax Expense | -- | -- | $0 | -- | -- | -- | -$203K | -- |
| **Net Income** | -$1.61M | $153.1M | -$1.39M | -$1.07M | -$1.59M | -$4.93M | -$5.58M | -$4.06M |
| Basic EPS | -$0.01 | -- | -$0.01 | $0.00 | -$0.01 | -- | -$0.10 | -$0.07 |
| **Diluted EPS** | -$0.01 | -- | -$0.01 | $0.00 | -$0.01 | -- | -$0.10 | -$0.07 |
| Basic Shares Outstanding | 98.5M | -- | 98.5M | 98.5M | 98.5M | -- | 54.4M | 54.4M |
| Diluted Shares Outstanding | 98.5M | -- | 98.5M | 98.5M | 98.5M | -- | 54.4M | 54.4M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.38M | $8.29M | $18.26M | $4.27M | $19.86M | $15.87M | $18.36M | $14.81M |
| Short-Term Investments | -- | -- | $0 | $27.33M | $51.36M | $56.90M | $93.93M | $66.71M |
| **Cash & Short-Term Investments** | $6.38M | $8.29M | $18.26M | $31.60M | $71.22M | $72.78M | $112.3M | $81.52M |
| **Total Current Assets** | $7.09M | $10.00M | $21.63M | $38.53M | $77.39M | $77.93M | $117.6M | $83.85M |
| Property, Plant & Equipment, Net | -- | $0 | $71K | $438K | $527K | $1.02M | $934K | $568K |
| Goodwill | -- | $0 | $881K | $881K | $881K | $881K | $881K | $881K |
| Intangible Assets | -- | -- | -- | -- | -- | $2.26M | $2.26M | $2.26M |
| Other Non-Current Assets | $101K | $100K | $90K | $1.88M | $1.96M | $1.48M | $918K | $497K |
| **Total Non-Current Assets** | $101K | $100K | $4.51M | $5.50M | $5.92M | $6.17M | $5.81M | $4.20M |
| **Total Assets** | $7.20M | $10.10M | $26.14M | $44.04M | $83.31M | $84.10M | $123.4M | $88.06M |
| Accounts Payable | $265K | $1.27M | $1.38M | $3.58M | $5.04M | $5.15M | $3.94M | $3.87M |
| **Total Current Liabilities** | $645K | $1.67M | $4.96M | $13.38M | $12.94M | $13.97M | $9.69M | $6.44M |
| **Total Non-Current Liabilities** | $0 | $152.1M | $152.4M | $139.8M | $128.4M | $64.01M | $44.07M | $20.53M |
| **Total Liabilities** | $645K | $153.8M | $157.3M | $153.2M | $141.3M | $77.98M | $53.77M | $26.97M |
| **Total Debt (incl. Leases)** | -- | -- | $1.25M | $44K | $302K | $534K | $831K | -- |
| Common Stock | $75K | $75K | $54K | $28K | $26K | $25K | $25K | -- |
| Retained Earnings | -$307.3M | -$456.4M | -$437.4M | -$378.3M | -$316.1M | -$235.6M | -$161.3M | -$104.8M |
| Accumulated Other Comp. Income | -- | -- | $0 | -$22K | -$14K | $12K | $38K | $3.0K |
| **Total Stockholders' Equity** | $3.97M | -$148.0M | -$131.2M | -$109.2M | -$58.00M | $6.12M | $69.61M | -$104.8M |
| Total Equity | $3.97M | -$148.0M | -$131.2M | -$109.2M | -$58.00M | $6.12M | $69.61M | -$104.8M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.50M | $6.38M | $4.47M | $5.23M | $6.69M | $8.29M | $8.46M | $10.75M |
| **Cash & Short-Term Investments** | $5.50M | $6.38M | $4.47M | $5.23M | $6.69M | $8.29M | $8.46M | $10.75M |
| **Total Current Assets** | $6.06M | $7.09M | $4.90M | $5.95M | $7.56M | $10.00M | $8.90M | $11.96M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | $0 | $0 | $56K |
| Goodwill | -- | -- | -- | -- | -- | $0 | $0 | $881K |
| Other Non-Current Assets | $101K | $101K | $101K | $101K | $101K | $100K | $2.0K | $90K |
| **Total Non-Current Assets** | $101K | $101K | $101K | $101K | $101K | $100K | $2.0K | $4.42M |
| **Total Assets** | $6.16M | $7.20M | $5.00M | $6.05M | $7.66M | $10.10M | $8.90M | $16.38M |
| Accounts Payable | $699K | $265K | $434K | $202K | $744K | $1.27M | $296K | $812K |
| **Total Current Liabilities** | -- | $645K | $598K | $347K | $975K | $1.67M | $914K | $2.13M |
| **Total Non-Current Liabilities** | -- | $0 | $151.0M | $151.0M | $151.0M | $152.1M | $151.0M | $152.3M |
| **Total Liabilities** | $1.14M | $645K | $151.6M | $151.4M | $152.0M | $153.8M | $152.0M | $154.4M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | -- | -- | $1.19M |
| Common Stock | $75K | $75K | $75K | $75K | $75K | $75K | $54K | $54K |
| Retained Earnings | -$308.9M | -$307.3M | -$460.4M | -$459.0M | -$458.0M | -$456.4M | -$451.4M | -$445.9M |
| **Total Stockholders' Equity** | $728K | $3.97M | -$149.2M | -$147.9M | -$147.2M | -$148.0M | -$143.1M | -$138.0M |
| Total Equity | $728K | $3.97M | -$149.2M | -$147.9M | -$147.2M | -$148.0M | -$143.1M | -$138.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $149.0M | -$18.96M | -$59.08M | -$62.22M | -$80.53M | -$74.22M | -$51.93M | -$23.68M |
| Depreciation & Amortization | $0 | $20K | $259K | $114K | $778K | $368K | $267K | $127K |
| Stock-Based Compensation | $410K | $2.54M | $5.56M | $7.16M | $7.23M | $5.54M | $2.39M | $865K |
| Change in Payables | -$1.01M | -$1.42M | -$2.21M | -$1.46M | -$101K | $1.20M | $77K | $1.59M |
| **Operating Cash Flow** | -$6.05M | -$12.14M | -$44.85M | -$43.43M | -$67.96M | -$59.54M | -$46.66M | -$22.17M |
| Capital Expenditure | -- | $0 | -$59K | -$25K | -$283K | -$457K | -$633K | -$347K |
| **Free Cash Flow** | -- | -$12.14M | -$44.91M | -$43.45M | -$68.24M | -$59.99M | -$47.29M | -$22.51M |
| Purchases of Investments | $0 | -$50K | $0 | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $3.50M | -$46K | $27.29M | $23.99M | $5.24M | $36.55M | -$27.82M | -$59.04M |
| Common Stock Issued | -- | $0 | $1.70M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $635K | $2.22M | $31.50M | $3.89M | $66.71M | $20.51M | $78.03M | $89.84M |
| **Net Change in Cash** | -$1.91M | -$9.97M | $13.94M | -$15.54M | $3.99M | -$2.48M | $3.54M | $8.64M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.61M | $153.1M | -$1.39M | -$1.07M | -$1.59M | -$4.93M | -$5.58M | -$4.06M |
| Depreciation & Amortization | -- | $0 | $0 | $0 | $0 | $0 | $5.0K | $6.0K |
| Stock-Based Compensation | $78K | $92K | $91K | $90K | $137K | $396K | $551K | $723K |
| Change in Payables | $434K | -$169K | $232K | -$542K | -$531K | -$337K | -$516K | -$234K |
| **Operating Cash Flow** | -$875K | -$1.60M | -$757K | -$1.46M | -$2.24M | -$2.34M | -$2.30M | -$2.72M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -$50K | $4.0K | $0 |
| **Financing Cash Flow** | $0 | $0 | $0 | $0 | $635K | $2.22M | $0 | $0 |
| **Net Change in Cash** | -$875K | $1.90M | -$757K | -$1.46M | -$1.60M | -$166K | -$2.29M | -$2.72M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 3750.6% | -- | -- | -- | -- | -1213.1% | -74.6% | -- |
| Return on Assets (ROA) | 2071.3% | -187.7% | -226.0% | -141.3% | -96.7% | -88.3% | -42.1% | -26.9% |
| Current Ratio | 11.00x | 6.00x | 4.36x | 2.88x | 5.98x | 5.58x | 12.13x | 13.01x |
| Quick Ratio | 9.88x | 4.98x | 3.68x | 2.36x | 5.51x | 5.21x | 11.58x | 12.65x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.09x | 0.01x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 20471.8% | 3750.6% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | 2417.8% | 2071.3% | -179.6% | -217.9% | -211.0% | -187.7% | -220.3% | -177.7% |
| Current Ratio | -- | 11.00x | 8.20x | 17.14x | 7.75x | 6.00x | 9.74x | 5.63x |
| Quick Ratio | -- | 9.88x | 7.48x | 15.07x | 6.86x | 4.98x | 9.25x | 5.06x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
